The Health Service Executive (HSE) in Ireland is preparing to recruit a new clinical lead for gender healthcare as its current head, Karl Neff, plans to step down by the end of 2026 after completing a draft model of care. Neff, who was appointed in 2024, will leave once the model is finalized. This transition occurs amid debate over the best approach to gender-affirming healthcare in Ireland. Some groups advocate for models allowing patient choice, such as the informed-consent approach used in Iceland, while others, like the National Gender Service, support stricter guidelines based on the UK’s Cass report. The Cass report criticized the use of puberty blockers for children, citing limited evidence of their effectiveness. Minister of State Mary Butler has expressed approval of Iceland’s model, having visited the country to study its system. The HSE aims to create a person-centered model of care that integrates services to meet the needs of individuals seeking gender-related healthcare.
Bias read (Center): The article presents multiple perspectives on the debate surrounding gender healthcare models in Ireland, including endorsements of the Icelandic informed-consent model by officials and criticism of the use of puberty blockers based on the Cass report. It does not favor one side over another and is,





